42.8 C
Delhi
Friday, May 17, 2024

Drugs Controller General of India (DCGI) approves Phase II/III clinical trial of COVAXIN in the age group of 2 to 18 years. Bharat Biotech to conduct trials in 525 healthy volunteers https://t.co/pp

anita
anita
Anita Choudhary is a freelance journalist. Writing articles for many organizations both in Hindi and English on different political and social issues

Related Articles

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Stay Connected

0FansLike
3,912FollowersFollow
0SubscribersSubscribe
- Advertisement -spot_img

Latest Articles